Concepedia

Samuel Kasera

SK

Statistics

Publications

1

Citations

247

H-Index

1

Active since

2022

Affiliations

Axios Biosciences (United States)(Current)

Samuel Kasera is an author at Axios Biosciences (United States) specializing in immune checkpoint inhibitors, oncology, and tumor-associated macrophage reprogramming.

ORCID

Publications per year

2022–2022

1

Publications

1

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity

Sushrut Kamerkar, Charan Leng, Olga Burenkova et al. · Science Advances · 2022 · 247 citations · Full text

, , +17

1–1 of 1